Register entry

MSD International GmbH

Data as of · How to read this entry

Registered sites
0
Active NDC listings
14
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

14

14 active NDC listings: 8 drug for further processing, 6 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 8, BULK INGREDIENT 6.

Dosage formNDCs
tablet, film coated8
powder6
RouteNDCs
Labeller name on the listingNDCs
msd international gmbh14
Catalogue

Marketed products

14
BrandGeneric nameForm / routeNDC
-BELZUTIFANtablet, film coated50473-0133DRUG FOR FURTHER PROCESSING
-Doravirine and Islatravir Monohydratetablet, film coated50473-0934DRUG FOR FURTHER PROCESSING
-ELBASVIRpowder50473-0097BULK INGREDIENT
-ELBASVIR and GRAZOPREVIRtablet, film coated50473-0091DRUG FOR FURTHER PROCESSING
-Enlicitide Decanoatepowder50473-0936BULK INGREDIENT
-GRAZOPREVIRpowder50473-0098BULK INGREDIENT
-ISLATRAVIR MONOHYDRATEpowder50473-0935BULK INGREDIENT
-LETERMOVIRtablet, film coated50473-0126DRUG FOR FURTHER PROCESSING
-LETERMOVIRtablet, film coated50473-0127DRUG FOR FURTHER PROCESSING
-RALTEGRAVIR POTASSIUMtablet, film coated50473-0001DRUG FOR FURTHER PROCESSING
-Suvorexantpowder50473-0029BULK INGREDIENT
-doravirinetablet, film coated50473-0124DRUG FOR FURTHER PROCESSING
-doravirine, lamivudine, and tenofovir disoproxil fumaratetablet, film coated50473-0125DRUG FOR FURTHER PROCESSING
-montelukast sodiumpowder50473-0002BULK INGREDIENT
Compare

Other companies listing letermovir

Enquiry

Common questions

Is MSD International GmbH FDA approved?
MSD International GmbH holds no registered establishment of its own; 14 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does MSD International GmbH make?
14 products are listed under MSD International GmbH in the openFDA NDC Directory, most often as tablet, film coated; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.